Name | 7H-Pyrrolo[2,3-d]pyrimidine-5-carboximidamide, 4-amino-N-hydroxy-7-.β.-D-ribofuranosyl |
---|
Description | NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors[1]. |
---|---|
Related Catalog | |
Target |
CDK9[1] |
References |
Density | 2.1g/cm3 |
---|---|
Boiling Point | 812ºC at 760mmHg |
Molecular Formula | C12H16N6O5 |
Molecular Weight | 324.29300 |
Flash Point | 444.9ºC |
Exact Mass | 324.11800 |
PSA | 182.76000 |
Vapour Pressure | 7.24E-28mmHg at 25°C |
Index of Refraction | 1.902 |